Adriaan E. Basson

Johannesburg, GT 2193, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Liquid Chromatography-Mass Spectrometry Metabolomic Analysis of Terminalia ferdinandiana Exell. Fruit Extracts That Inhibit HIV-1 Cell Infection, HIV-1 Reverse Transcriptase and HIV-1 Protease.

Liquid Chromatography-Mass Spectrometry Metabolomic Analysis of Terminalia ferdinandiana Exell. Fruit Extracts That Inhibit HIV-1 Cell Infection, HIV-1 Reverse Transcriptase and HIV-1 Protease.

Journal: Molecules (Basel, Switzerland)

Published: March 17, 2025

Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir.

Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir.

Journal: Viruses

Published: October 18, 2024

Causes of death in adults living with HIV in South Africa: A single-centre postmortem study.

Causes of death in adults living with HIV in South Africa: A single-centre postmortem study.

Journal: Southern African journal of HIV medicine

Published: October 17, 2024

Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A thorough Pharmacological Analysis.

Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A thorough Pharmacological Analysis.

Journal: Journal of medicinal chemistry

Published: October 16, 2024

K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine.

K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine.

Journal: Viruses

Published: August 28, 2024

Expanding the toolbox of metabolically stable lipid prodrug strategies.

Expanding the toolbox of metabolically stable lipid prodrug strategies.

Journal: Frontiers in pharmacology

Published: October 28, 2022

ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic Properties.

ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic Properties.

Journal: Journal of medicinal chemistry

Published: August 30, 2021

HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance.

HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance.

Journal: PloS one

Published: April 02, 2020

Drug susceptibility and replication capacity of a rare HIV-1 subtype C protease hinge region variant.

Drug susceptibility and replication capacity of a rare HIV-1 subtype C protease hinge region variant.

Journal: Antiviral therapy

Published: March 10, 2019

Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.

Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.

Journal: ACS medicinal chemistry letters

Published: November 15, 2018

Double trouble? Gag in conjunction with double insert in HIV protease contributes to reduced DRV susceptibility.

Double trouble? Gag in conjunction with double insert in HIV protease contributes to reduced DRV susceptibility.

Journal: The Biochemical journal

Published: August 24, 2018

Application of the Huisgen cycloaddition and 'click' reaction toward various 1,2,3-triazoles as HIV non-nucleoside reverse transcriptase inhibitors.

Application of the Huisgen cycloaddition and 'click' reaction toward various 1,2,3-triazoles as HIV non-nucleoside reverse transcriptase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: April 29, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026